Phase II Study of CG100649 for Primary Osteoarthritis in Male Subjects

NCT00530452 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

240

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoarthritis, Knee
Osteoarthritis, Hip

Interventions

DRUG: CG100649
DRUG: Silicified microcrystalline cellulose + talc

Sponsor

CrystalGenomics, Inc.

Collaborators

[object Object]